Cell Based Assays Market
Cell Based Assays Market (Product Type - Instruments, Assay Kits, Reagents and Consumables, Software, and Services; End Users - Pharmaceutical and Biotech Companies, Academic Institutions, and Contract Research Organizations; Applications - Drug Discovery, Basic Research, and Predictive Toxicology) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022
Press Release :
Global Cell Based Assays Market: Overview
The global cell based assays market is projected to witness a substantial growth over the forecast period of 2017 to 2022, says the recent report by Transparency Market Research. According to the report the market is expected to grow with an astounding 7.7% CAGR. This growth is majorly attributed to factors such as growing prevalence of chronic diseases, increasing government support and research and development. Moreover, improving healthcare infrastructure in Asia Pacific is expected to boost the global cell based assays market to US$ 19.71 bn by the end of 2022, where it stood at US$ 13.57 bn in 2017.
The report provides in-depth analysis of global cell based assays market to the readers, which help them make better decision in the future. Moreover, statistics on facets such as developments, competitive landscape, challenges and opportunities allow the players to derive action plans for a sustainable future in the global cell based assays market from 2017 to 2022.
Global Cell Based Assays Market: Trends and Drivers
Demand for New Drugs to Boost the Growth
The global cell based assays market is driven progressively by the extensive utilization of the techniques in new drugs developments by pharmaceutical companies. The applications are eminently reinforced by quickly rising number of medications for deadly ailments in various regions of the world. The predominance of cardiovascular ailments and diabetes is additionally filling the interest for cell-based assays across the globe. Moreover, the growth of global cell based assays market is molded by the rising interest for progressive drugs developments for different dangerous ailments. The developing job of cell-based tests in sedate disclosure for disease is a valid example. Developing job of cell-based examines in quickening time-to-market of medications by pharmaceutical and biotech organizations is a key pattern supporting in the fast walk of the global cell based assays market.
Global Cell Based Assays Market: Segmentation
Consumables and Reagents Hold Lion’s Share in the Market
On the basis of end-user, the global cell based assays market is divided into pharmaceutical and biotechnology organizations, scholastic foundations, contract research associations. At present, pharmaceutical and biotechnology organizations serve the most extreme interest, which is an impression of developing reception of cell-based examines for medicate revelation by the end clients, particularly in the created nations inside North America and Europe. Application-wise, the global cell based assays market has been arranged into sedate disclosure, prescient toxicology, fundamental research, and different applications.
In terms of product types category, the worldwide cell based assays market has been portioned into instruments, reagents and consumables, measure units, administrations, and programming. Among these, reagents and consumables segment comprised 32.1% of overall growth of global cell based assays market in 2017, which was worth US$4.5 bn in 2017. Expanding adoption of cell-based consumables by noticeable biopharmaceutical organizations and developing number of CROs are some more factors responsible for the growth of the segment in coming years. By the end of the time frame, 2022, the reagents and consumables portion is relied upon to lose a tad of ground, despite the fact that it will remain the most beneficial item type, promising demands worth of US$6.2 bn by 2022. This fragment alone is anticipated for a CAGR of 7.5% during the said figure time frame.
Global Cell Based Assays Market: Regional Analysis
North America to Account for Largest Share
North America is expected to account for the largest share in the global cell based assays market. This growth is the result of the growth in the research and development by various pharmaceutical companies to develop new drugs for treatment of chronic diseases. The region is expected to bag US$ 7.7 bn by 2022 with CAGR of whopping 8.2% during the forecast period.
Global Cell Based Assays Market: Overview
This report on the global cell based assays market analyzes the current and future scenario of the global market. rising incidence of chronic diseases, growing availability of funds for research, growing preference for cell-based assays, increasing drug discovery activity, and widespread opportunities in the emerging economies in the region of Asia Pacific are some of the key factors driving the global cell based assays market, which, on the other hand, is obstructed by high cost of investment and restrictions pertaining to the usage of reagent
The global cell based assays market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product type, end users, application, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises dynamics of the market, supply chain, cost structure, pricing analysis, raw material sourcing strategy and analysis, and supplier list. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global cell based assays market.
Global Cell Based Assays Market: Research Methodologies
To compute the market size, in-depth secondary research is done. Data points such as regional splits and market split by product type, application, and end use type have been assimilated to arrive at the market estimates. TMR triangulates the data via different analysis based on supply side, demand side, as well as dynamics of cell based assays market. TMR not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market. Vital feature of this report is the analysis of the global cell based assays market by product type, end use type, application, and region; and the corresponding revenue forecast in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve as well as to provide potential resources from sales perspective of the cell based assays market.
Global Cell Based Assays Market: Segmentations
On the basis of product type, the global cell based assays market has been segmented into instruments, assay kits, reagents and consumables, software, and services. On the basis of end-user, the global cell based assays market has been bifurcated into pharmaceutical and biotechnology companies, academic institutions, contract research organizations, and other end-users such as clinical laboratories, hospitals, and environmental monitoring labs. Application-wise, the global cell based assays market has been categorized into drug discovery, predictive toxicology, basic research, and other applications.
Global Cell Based Assays Market: Competitive Landscape
Some of the key companies currently holding position of strength in the global cell based assays market are GE Healthcare, Becton, Dickinson and Company, Danahar Corporation, Cisbio Bioassays, Cell Signaling Technology, Life Technologies Corporation, Merck KGaA, Essen Bioscience, Discoverx Corporation, Thermo Fisher Scientific Inc., Perkinelmer Inc., Promega Corporation, Proqinase GmbH, Enzo Life Sciences, Inc., Charles River Laboratories International, Inc., Biospherix, Ltd., Selexis SA, Marine Biological Laboratory, Biotek Instruments, Inc., Miltenyi Biotec, Bioagilytix Labs., Lonza, Aurelia Bioscience Ltd., Cell Biolabs, Inc., and Qgel SA. For each of these companies, the report provides business overview, number of employees, brand overview, key competitors, business overview, business strategies, recent/key developments, acquisitions, and financial overview (wherever applicable).